Discover 1 curated intelligence briefings related to this specific topic.
Inside the nuclear medicine hubs of Seoul, a contrarian approach to Stage IV cancer is emerging. By weaponizing isotopes, clinicians are bypassing the collateral damage of chemotherapy to target metastatic tumors with surgical precision.